Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer

Carobene A., Guerra E., Locatelli M., Cucchiara V., Briganti A., Aarsand A. K., ...Daha Fazla

CLINICA CHIMICA ACTA, cilt.486, ss.185-191, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 486
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.cca.2018.07.043
  • Dergi Adı: CLINICA CHIMICA ACTA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.185-191
  • Anahtar Kelimeler: Biological variation, Analytical performance specification, Prostate specific antigen, Prostate cancer, REFERENCE CHANGE VALUES, LABORATORY MEDICINE, CLINICAL-CHEMISTRY, QUALITY SPECIFICATIONS, STORAGE-CONDITIONS, SERUM, VARIABILITY, COLLECTION, VOLUNTEERS, FEDERATION
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Background: Prostate-specific antigen (PSA) is central in the diagnosis of prostate cancer. However, high-quality biological variation (BV) estimates for PSA are scarce. Here BV estimates from the European Biological Variation Study (EuBIVAS) for total (tPSA), free (fPSA), conjugated PSA (cPSA), and percent free PSA (%fPSA) are provided.